Buscar
Mostrando ítems 1-10 de 43
Neurosensory dysfunction: a diagnostic marker of early COVID-19
Objectives
To detailly described the neurosensory dysfunction, including hyposmia, hypogeusia
and tinnitus, in patients with COVID-19.
Methods
Clinical characteristics and oropharyngeal swabs were obtained from 86 ...
Neurosensory dysfunction: a diagnostic marker of early COVID-19
Objectives
To detailly described the neurosensory dysfunction, including hyposmia, hypogeusia
and tinnitus, in patients with COVID-19.
Methods
Clinical characteristics and oropharyngeal swabs were obtained from 86 ...
COVID-19 and anosmia in Tehran, Iran
Patients with acute olfactory disorders typically present to the otolaryngologist with both acute hyposmia and
less often with anosmia. With the onset of COVID-19 we have noticed an increase in the number of patients ...
The close relationship between sudden loss of smell and COVID-19
Introduction: The real number of COVID-19 cases may be underestimated since several countries have difficulty offering laboratory tests for all the population. Therefore, finding a
symptom with a high predictive value ...
Phantosmia May Predict Long‐Term Measurable Olfactory Dysfunction After COVID‐19
(WILEY, 2022)
Objectives Persistent olfactory dysfunction (OD) after 6 months caused by SARS-CoV-2 infection has been reported with a variable prevalence worldwide. This study aimed to determine the prevalence of long-term OD and identify ...
Diagnostic Value of Combined Acute Levodopa Challenge and Olfactory Testing to Predict Parkinson's Disease
(Wiley, 2017-11)
Background: The diagnosis of Parkinson's disease (PD) can be challenging early in the diseasecourse, when motor features are subtle. The objective of this study was to explore the diagnostic value ofcombining acute levodopa ...
Factors associated with depression in patients with Parkinson’s disease, A multicenter study in Lima, Peru
(Dement NeuropsycholPE, 2018)
The diagnosis and treatment of depression in patients with Parkinson’s disease (PD) is inadequate, often
contributing to a reduced quality of life, rapid disease progression, higher cognitive impairment, and an increased ...
[Current genetic issues and phenotypic variants in Kallmann syndrome]
(2012)
Kallmann syndrome is characterized by hypogonadotropic hypogonadism and anosmia/hyposmia. The hypogonadotropic hypogonadism is due to deficiency of gonadotropin-releasing hormone, caused by a defect in the migration of ...
[Current genetic issues and phenotypic variants in Kallmann syndrome]. [Síndrome de Kallmann. Aspectos genéticos y variantes fenotípicas.]
(2012)
Kallmann syndrome is characterized by hypogonadotropic hypogonadism and anosmia/hyposmia. The hypogonadotropic hypogonadism is due to deficiency of gonadotropin-releasing hormone, caused by a defect in the migration of ...